Göbel D, Schultz W
Orthopädische Praxisklinik, Donaueschingen.
Z Orthop Unfall. 2008 Sep-Oct;146(5):602-8. doi: 10.1055/s-2008-1038609. Epub 2008 Oct 9.
To evaluate the differences in clinical outcome and economics of primary total knee replacements, the results with two implant types (cruciate retaining and sacrificing) were analysed.
From 1/2000 until 6/2001 twenty-two consecutive patients with primary arthrosis of the knee underwent total knee replacement with the cruciate-retaining CKS-CC knee system (= group 1: 9 men, 13 women, mean age 65.68 years). Between 8/2001 and 3/2002 twenty-two consecutive patients received the cruciate-sacrificing NexGen Full Flex implant (= group 2: 4 men, 18 women, mean age 67.18 years). The operative procedures and rehabilitation regimes were standardised. The modified Insall score, patient satisfaction, as well as implant and rehabilitation costs were evaluated. Statistical analyses were based on two theses. I) There is no difference between the clinical early and five-year results of both groups. II) The more expensive NexGen implant is less economic regarding total costs per patient.
The more expensive, cruciate-sacrificing NexGen implant showed significantly better clinical results (p = 0.0005) and higher patient satisfaction while rehabilitation costs were lower (p = 0.003). While the clinical results remained unchanged, the revision rate after 5 years for the NexGen System was lower.
Not only minimally invasive surgery, but also choosing the right type of implant may lead to better early as well as mid-term clinical results in primary total knee arthroplasty. This may also reduce total costs per patient in primary total knee arthroplasty.
为评估初次全膝关节置换术的临床疗效及经济性差异,分析了两种植入物类型(保留交叉韧带型和牺牲交叉韧带型)的手术结果。
从2000年1月至2001年6月,22例连续性膝关节原发性骨关节炎患者接受了保留交叉韧带的CKS-CC膝关节系统全膝关节置换术(=第1组:9名男性,13名女性,平均年龄65.68岁)。在2001年8月至2002年3月期间,22例连续性患者接受了牺牲交叉韧带的NexGen全屈曲植入物(=第2组:4名男性,18名女性,平均年龄67.18岁)。手术操作和康复方案均标准化。评估改良Insall评分、患者满意度以及植入物和康复费用。统计分析基于两个假设。I)两组的临床早期和五年结果无差异。II)更昂贵的NexGen植入物在每位患者的总成本方面经济性较差。
更昂贵的牺牲交叉韧带的NexGen植入物显示出显著更好的临床效果(p = 0.0005)和更高的患者满意度,而康复费用更低(p = 0.003)。虽然临床效果保持不变,但NexGen系统5年后的翻修率更低。
在初次全膝关节置换术中,不仅微创手术,而且选择合适类型的植入物可能会带来更好的早期和中期临床效果。这也可能降低初次全膝关节置换术每位患者的总成本。